Strategy
MSTR
Coinbase
COIN
Tesla
TSLA
Vale SA
VALE
NVIDIA
NVDA
US Stock MarketDetailed Quotes
BDTX Black Diamond Therapeutics
- 1.690
- -0.020-1.17%
Close Mar 11 16:00 ET
- 1.690
- 0.0000.00%
Post 16:20 ET
95.76MMarket Cap-1.33P/E (TTM)
1.783High1.605Low508.15KVolume1.740Open1.710Pre Close843.62KTurnover1.30%Turnover RatioLossP/E (Static)56.66MShares7.66052wk High1.15P/B65.91MFloat Cap1.59052wk Low--Dividend TTM39.00MShs Float46.250Historical High--Div YieldTTM10.42%Amplitude1.180Historical Low1.660Avg Price1Lot Size
Black Diamond Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 6.62%-62.3M | -7.87%-15.06M | 38.33%-11.32M | -2.49%-14.73M | -5.83%-21.2M | 21.59%-66.72M | 36.39%-13.96M | -11.45%-18.36M | 20.47%-14.37M | 29.96%-20.03M |
| Net income from continuing operations | 15.48%-69.68M | 17.64%-15.99M | 32.38%-15.56M | -3.95%-19.91M | 12.69%-18.23M | 9.57%-82.44M | 7.92%-19.41M | -6.25%-23.01M | 16.48%-19.15M | 18.16%-20.88M |
| Operating gains losses | -126.26%-94K | ---8K | -114.95%-48K | ---- | ---- | 2,005.88%358K | --0 | 6,320.00%321K | --0 | --37K |
| Depreciation and amortization | -21.51%343K | -1.16%85K | -25.22%86K | -24.56%86K | -29.51%86K | -13.98%437K | -31.75%86K | -10.85%115K | -10.94%114K | -2.40%122K |
| Other non cash items | 5.58%2.97M | 5.57%758K | 5.65%748K | 5.59%737K | 5.51%728K | 3.08%2.81M | 5.43%718K | 4.42%708K | 1.90%698K | 0.58%690K |
| Change In working capital | -173.03%-2.69M | -120.79%-816K | 99.52%2.48M | -83.37%217K | -64.06%-4.57M | 137.23%3.69M | 184.17%3.93M | -22.97%1.24M | 97.13%1.31M | 62.92%-2.79M |
| -Change in prepaid assets | -98.54%33K | 60.38%255K | 37.95%927K | -116.75%-176K | -354.05%-973K | 122.50%2.27M | -91.62%159K | -22.85%672K | 17.17%1.05M | 114.46%383K |
| -Change in payables and accrued expense | -79.56%927K | -104.96%-227K | 74.63%2.36M | 53.88%1.57M | -14.83%-2.77M | 156.03%4.54M | 178.72%4.58M | -6.44%1.35M | 120.61%1.02M | 42.28%-2.41M |
| -Change in other current assets | ---249K | --44K | --44K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| -Change in other current liabilities | -9.28%-3.4M | -9.09%-888K | -9.32%-856K | -9.44%-835K | -9.28%-824K | -9.61%-3.11M | -9.56%-814K | -9.51%-783K | -9.63%-763K | -9.75%-754K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 6.62%-62.3M | -7.87%-15.06M | 38.33%-11.32M | -2.49%-14.73M | -5.83%-21.2M | 21.59%-66.72M | 36.39%-13.96M | -11.45%-18.36M | 20.47%-14.37M | 29.96%-20.03M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 3.81%16.97M | 126.70%27.77M | 105.79%2.19M | -95.69%740K | -155.37%-13.73M | -69.37%16.35M | 427.52%12.25M | -361.14%-37.88M | -13.29%17.18M | 48.28%24.81M |
| Net PPE purchase and sale | 51.61%94K | --8K | 245.45%48K | ---- | ---- | 133.88%62K | --0 | -512.50%-33K | ---- | ---- |
| Net investment purchase and sale | 3.62%16.87M | 126.64%27.76M | 105.67%2.15M | -95.89%702K | -155.37%-13.73M | -69.59%16.28M | 429.57%12.25M | -361.06%-37.85M | -14.60%17.08M | 48.22%24.81M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 3.81%16.97M | 126.70%27.77M | 105.79%2.19M | -95.69%740K | -155.37%-13.73M | -69.37%16.35M | 427.52%12.25M | -361.14%-37.88M | -13.29%17.18M | 48.28%24.81M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -64.48%25.55M | 732.61%291K | -100.35%-252K | 21.38M | 7,998.04%4.13M | 40,539.55%71.93M | -64.29%-46K | 138,221.15%71.93M | 0 | -66.67%51K |
| Net common stock issuance | -65.91%24.49M | --0 | -100.70%-500K | --21.01M | --3.98M | --71.85M | --0 | --71.85M | --0 | --0 |
| Proceeds from stock option exercised by employees | 1,184.15%1.05M | 732.61%291K | 222.08%248K | --364K | 194.12%150K | -53.67%82K | -64.29%-46K | 48.08%77K | --0 | -66.67%51K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -64.48%25.55M | 732.61%291K | -100.35%-252K | --21.38M | 7,998.04%4.13M | 40,539.55%71.93M | -64.29%-46K | 138,221.15%71.93M | --0 | -66.67%51K |
| Net cash flow | ||||||||||
| Beginning cash position | 60.76%57.04M | -58.75%24.25M | -21.99%33.63M | -34.90%26.24M | 60.76%57.04M | -47.06%35.48M | 6.66%58.8M | -24.42%43.12M | -27.11%40.31M | -47.06%35.48M |
| Current changes in cash | -191.78%-19.79M | 841.87%13.01M | -159.83%-9.38M | 163.34%7.39M | -738.27%-30.8M | 168.36%21.56M | 91.08%-1.75M | 918.00%15.68M | 61.23%2.81M | 141.18%4.83M |
| End cash Position | -34.69%37.26M | -34.69%37.26M | -58.75%24.25M | -21.99%33.63M | -34.90%26.24M | 60.76%57.04M | 60.76%57.04M | 6.66%58.8M | -24.42%43.12M | -27.11%40.31M |
| Free cash flow | 6.66%-62.3M | -7.87%-15.06M | 38.45%-11.32M | -2.49%-14.73M | -5.83%-21.2M | 21.72%-66.75M | 36.39%-13.96M | -11.70%-18.4M | 21.31%-14.37M | 29.98%-20.03M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.